OVERVIEW
Join us for this 90-minute interactive symposium that will feature a panel of experts on chronic lymphocytic leukemia (CLL). The panel will review the intricacies of patient care in the era of modern therapies, including personalized treatment selection, managing CLL in the setting of comorbid disease, measurable residual disease (MRD) and biomarker testing, and mitigation and management of adverse events. Attendees will have the opportunity to participate in interactive case studies with the panelists to work through complex patient scenarios that can be applied to real-world practice. The session will end with an audience Q&A during which the panelists will provide expert insight into your questions and challenges.
GOAL STATEMENT
The goal of this activity is that learners will be better able to obtain practical strategies to personalize treatment and manage side effects for patients with treatment-naive or relapsed/refractory (R/R) CLL.
LEARNING OBJECTIVES
Upon completion of this activity, participants will be better able to: [LIST][ITEM]Discuss the evidence supporting MRD testing in CLL [ITEM]Apply personalized therapy for patients with treatment-naive CLL [ITEM]Explore sequencing therapy for patients with R/R CLL [ITEM]Demonstrate their ability to work as part of an interprofessional team to manage side effects of CLL treatments[/LIST]
ACCREDITATION STATEMENT
In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
[bold]For Physicians[/bold] The University of Nebraska Medical Center designates this live activity for a maximum of 1.5 [italic]AMA PRA Category 1 Credits[/italic]™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] The University of Nebraska Medical Center designates this activity for up to 1.5 contact hours. Nurses should only claim credit for the actual time spent participating in the activity.
Grand Hyatt Kauai Resort & Spa
1571 Poipu Rd Grand Ballroom 1, 7, 6, 2
Koloa, Hawaii, 96756
United States
Held in conjunction with the 2022 Pan Pacific Lymphoma Conference.
Supported by independent educational grants from [bold]AstraZeneca Pharmaceuticals LP, Pharmacyclics LLC, An AbbVie Company,[/bold] and [bold]Janssen Biotech, Inc[/bold].
Organized by
